These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The use of sugammadex in a patient with myasthenia gravis. Unterbuchner C; Fink H; Blobner M Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151 [TBL] [Abstract][Full Text] [Related]
4. Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy. de Boer HD; van Esmond J; Booij LH; Driessen JJ Paediatr Anaesth; 2009 Dec; 19(12):1226-8. PubMed ID: 19863737 [TBL] [Abstract][Full Text] [Related]
5. Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients. McDonagh DL; Benedict PE; Kovac AL; Drover DR; Brister NW; Morte JB; Monk TG Anesthesiology; 2011 Feb; 114(2):318-29. PubMed ID: 21239968 [TBL] [Abstract][Full Text] [Related]
7. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567 [TBL] [Abstract][Full Text] [Related]
8. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine. Sacan O; White PF; Tufanogullari B; Klein K Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210 [TBL] [Abstract][Full Text] [Related]
9. A novel approach to reversal of neuromuscular blockade. Della Rocca G; Pompei L Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157 [TBL] [Abstract][Full Text] [Related]
11. Reversal of profound neuromuscular blockade with sugammadex after failure of rapid sequence endotracheal intubation: a case report. Barbosa FT; da Cunha RM Rev Bras Anestesiol; 2012; 62(2):281-4. PubMed ID: 22440384 [TBL] [Abstract][Full Text] [Related]
12. Sugammadex: a revolutionary approach to neuromuscular antagonism. Kopman AF Anesthesiology; 2006 Apr; 104(4):631-3. PubMed ID: 16571954 [No Abstract] [Full Text] [Related]
13. Reversal of neuromuscular block with a selective relaxant-binding agent: sugammadex. Ren WH; Jahr JS Am J Ther; 2009; 16(4):295-9. PubMed ID: 19535969 [TBL] [Abstract][Full Text] [Related]
14. Magnesium-induced recurarisation after reversal of rocuronium-induced neuromuscular block with sugammadex. Findings vs. speculation. Carron M; Ori C Acta Anaesthesiol Scand; 2015 Aug; 59(7):946-7. PubMed ID: 25962433 [No Abstract] [Full Text] [Related]
15. Sugammadex: the first selective binding reversal agent for neuromuscular block. Kovac AL J Clin Anesth; 2009 Sep; 21(6):444-53. PubMed ID: 19833281 [TBL] [Abstract][Full Text] [Related]
16. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156 [TBL] [Abstract][Full Text] [Related]
17. In reply. Pongrácz A; Nemes R; Fülesdi B; Tassonyi E Anesthesiology; 2014 Feb; 120(2):508-9. PubMed ID: 24448083 [No Abstract] [Full Text] [Related]
18. A randomized simultaneous comparison of acceleromyography with a peripheral nerve stimulator for assessing reversal of rocuronium-induced neuromuscular blockade with sugammadex. Drobnik L; Sparr HJ; Thörn SE; Khuenl-Brady KS; Rietbergen H; Prins ME; Ullman J Eur J Anaesthesiol; 2010 Oct; 27(10):866-73. PubMed ID: 20523215 [TBL] [Abstract][Full Text] [Related]
19. [Sugammadex: a new approach to muscle relaxation and its reversal]. Duvaldestin P Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S39-40. PubMed ID: 19887275 [No Abstract] [Full Text] [Related]
20. Novel pharmacological approaches for the antagonism of neuromuscular blockade. Pic LC AANA J; 2005 Feb; 73(1):37-40. PubMed ID: 15727282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]